查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
連接酶市場 - 2017-2027 年全球行業規模、佔有率、趨勢、機會和預測，按產品、來源、按應用、最終用戶、公司和地區細分
市場調查報告書
商品編碼
1303140

連接酶市場 - 2017-2027 年全球行業規模、佔有率、趨勢、機會和預測，按產品、來源、按應用、最終用戶、公司和地區細分

Ligase Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product, By Source, By Application, By End User, By company and By Region
出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計全球連接酶市場在2023-2027年預測期內將出現令人印象深刻的成長。主要因素包括傳染病、遺傳病和慢性病患病率的上升以及研發活動的增加推動市場的成長。連接酶是透過連接兩個分子形成新的化學鍵來催化反應的酶。連接酶在分子診斷方法中發揮著非常重要的作用，因為它確保了標靶治療的安全有效的應用。支持市場成長的其他因素包括疾病治療需求的增加、研發投資的增加、研發的不斷成長、診斷和製藥公司的擴張、先進技術的採用以及世界人口的成長。此外，不斷增加的戰略成長（例如合併、合作和收購）加強市場的成長。例如，2021年，BLIRT SA 擴大了其位於格但斯克科技園區的實驗室設施。新實驗室致力於擴大關鍵酶的生產規模並改進生產流程。

疾病治療中對連接酶的需求不斷成長

全球慢性病、傳染病和遺傳性疾病發病率的激增推動市場的成長。患有這些疾病之一的患者數量不斷增加是促成因素。因此，對更好的治療以提供更好的患者護理的需求推動市場的成長。由於不健康的選擇、生活方式的改變、速食的消費等，不僅老年人口，年輕一代也容易患上這些疾病。因此，加強了市場的成長。例如，根據世界衛生組織的資料，每年有1790萬人死於心血管疾病，其次是930萬人死於癌症，410萬人死於慢性呼吸道疾病，最後是200萬人死於糖尿病（包括腎病） 。同樣，根據世界衛生組織的估計，每1000人中就有10人患有遺傳病。

增加研發和大量投資推動市場成長

全球範圍內使用連接酶作為治療干涉措施的研發 (R&D) 活動的興起推動市場的成長。由於研究活動的增加，它們用於多種目的，如突變檢測、克隆、藥物標靶等，推動了市場的成長。例如，2022年3月，一項名為“SUMO E3 Ligases in Signaling Pathway of Cancer Cells”的研究指出，小型類泛素修飾（SUMO）化是一種可逆的轉譯後修飾，在多種癌症中發揮著非常重要的作用。細胞生理學的各個方面，包括細胞週期調節、蛋白質運輸和 DNA 損傷修復，這些對於細胞穩態非常重要。此外，酶分子診斷研發活動投資的增加促進市場的成長。2021年，Merck在達姆施塔特全球總部投資了2.825億美元。該公司正致力於為其醫療保健業務部門建設一個新的轉化科學中心和一個新的學習中心。

可用的客製化

根據給定的市場資料，TechSci Research 可根據公司的具體需求提供客製化服務。本報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球連接酶市場的影響

第5章：客戶之聲

第6章：全球連接酶市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 副產品（快速連接酶、T4 DNA 連接酶、大腸桿菌 DNA 連接酶、T4 RNA 連接酶、其他）
    • 按來源（古細菌、大腸桿菌、嗜熱棲熱菌、其他）
    • 按應用（連接酶鍊式反應、連接酶檢測反應、下一代測序、分子克隆等）
    • 按最終用戶（生物技術和製藥公司、學術和研究機構、其他）
    • 按地區
    • 按公司分類 (2021)
  • 市場地圖

第7章：北美連接酶市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品分類
    • 按來源
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第8章：歐洲連接酶市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品分類
    • 按來源
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第9章：亞太連接酶市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品分類
    • 按來源
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第10章：南美連接酶市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品分類
    • 按來源
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章：中東和非洲連接酶市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品分類
    • 按來源
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非連接酶
    • 沙烏地阿拉伯連接酶
    • 阿拉伯聯合大公國連接酶

第12章：市場動態

  • 駕駛者
  • 挑戰

第13章：市場趨勢與發展

第14章：競爭格局

  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Codexis, Inc.
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • Promega Corporation
  • QIAGEN N.V.
  • ArcticZymes Technologies ASA
  • Thermo Fisher Scientific, Inc.
  • Takara Bio Inc.

第15章：戰略建議

簡介目錄
Product Code: 13055

The global ligase market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include the rising prevalence of infectious, genetic, and chronic diseases and the increase in R&D activities are impelling the growth of the market. Ligases are enzymes that catalyze the reaction by joining two molecules to form a new chemical bond. Ligase has a crucial role in the molecular diagnostics method, as it makes sure the safe and effective application of targeted therapeutics. The other factors supporting the market's growth are, increasing demand for disease treatment, increasing investments in R&D, growing research & development, expansion of diagnostics and pharmaceutical companies, adoption of advanced technology, and rising world population. Also, the increasing strategic growth, such as mergers, collaborations, and acquisitions, is strengthening the growth of the market. For instance, in 2021, BLIRT S.A. enlarged its laboratory facility at Technology Park and Gdansk Science. The new laboratory is involved in growing its production scale for key enzymes and improving production processes.

Growing Need for Ligases in Disease Treatment

The surge in incidences of chronic diseases, infectious diseases, and genetic disorders across the globe is bolstering the growth of the market. The rising number of patients suffering from one of these diseases is a contributing factor. Thus, the need for better treatment to provide better patient care is fueling the growth of the market. Not only the geriatric population but the younger generation are prone to these diseases due to unhealthy choices, lifestyle changes, consumption of fast foods, and others. Thus, strengthening the growth of the market. For instance, according to WHO, every year, 17.9 million people die from cardiovascular diseases, followed by 9.3 million deaths by cancer, 4.1 million deaths from chronic respiratory diseases, and lastly, 2.0 million deaths caused by diabetes, including kidney disease. Similarly, according to the estimation of WHO, 10 out of every 1000 people are affected by genetic diseases.

Increasing R&D and Heavy Investments Fuels the Market Growth

The rise in research and development (R&D) activities across the globe to use ligase as a therapeutic intervention is propelling the growth of the market. Owing to the increase in research activities, they are used for various purposes such as mutation detection, cloning, drug targets, and others, thus, in turn, impelling the growth of the market. For instance, in March 2022, a research study named "The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells" stated that small ubiquitin-like modifier (SUMO)ylation is a reversible post-translational modification that plays a vital role in several aspects of cell physiology, including cell cycle regulation, protein trafficking, and DNA damage repair, which are essential for cell homeostasis. Moreover, the rising investments in R&D activities for enzyme-based molecular diagnostics are facilitating the growth of the market. In 2021, Merck invested $282.5 million at its global headquarters in Darmstadt. The company is focusing on building a new translational science center for its healthcare business sector and a new learning center.

Market Segmentation

The global ligase market is segmented into product, source, application, end user, and company. Based on product, the market is segmented into quick ligase, T4 DNA ligase, E.Coli DNA ligase, T4 RNA ligase, and others. Based on the source, the market is segmented into Archaebacterium, escherichia coli, Thermus thermophilus, and others. Based on application, the market is segmented into ligase chain reaction, ligase detection reaction, next-generation sequencing, molecular cloning, and others. Based on end-user, the market is divided into biotechnology & pharmaceutical companies, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising number of research and development and clinical trial programs in the country.

Market Players

Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Codexis, Inc., F. Hoffmann-La Roche AG, Merck KGaA, Promega Corporation, QIAGEN N.V., ArcticZymes Technologies ASA, Thermo Fisher Scientific, Inc., and Takara Bio Inc. are some of the leading companies operating in the market.

Report Scope

In this report, global ligase market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Ligase Market, By Product:

  • Quick Ligase
  • T4 DNA Ligase
  • E.Coli DNA Ligase
  • T4 RNA Ligase
  • Others

Ligase Market, By Source:

  • Archaebacterium
  • Escherichia coli
  • Thermus thermophilus
  • Others

Ligase Market, By application:

  • Ligase Chain Reaction
  • Ligase Detection Reaction
  • Next-Generation Sequencing
  • Molecular Cloning
  • Others

Ligase Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutions
  • Others

Ligase Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Ligase Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Ligase Market

5. Voice of Customer

6. Global Ligase Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Quick Ligase, T4 DNA Ligase, E.Coli DNA Ligase, T4 RNA Ligase, Others)
    • 6.2.2. By Source (Archaebacterium, Escherichia coli, Thermus thermophilus, Others)
    • 6.2.3. By Application (Ligase Chain Reaction, Ligase Detection Reaction, Next Generation Sequencing, Molecular Cloning, Others)
    • 6.2.4. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 6.2.5. By Region
    • 6.2.6. By Company (2021)
  • 6.3. Market Map

7. North America Ligase Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Source
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Ligase Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Source
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Mexico Ligase Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Source
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Canada Ligase Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Source
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Ligase Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Source
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Ligase Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Source
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Ligase Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Source
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Ligase Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Source
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Ligase Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Source
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Ligase Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Source
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Ligase Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Source
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Ligase Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Source
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. India Ligase Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Source
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Japan Ligase Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Source
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Ligase Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Source
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Ligase Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Source
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Ligase Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Source
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Ligase Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Source
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Ligase Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Source
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Ligase Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Source
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Ligase Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Source
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Ligase Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Source
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Ligase Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Source
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Ligase Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Source
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Bio-Rad Laboratories, Inc.
  • 14.2. Agilent Technologies, Inc.
  • 14.3. Codexis, Inc.
  • 14.4. F. Hoffmann-La Roche AG
  • 14.5. Merck KGaA
  • 14.6. Promega Corporation
  • 14.7. QIAGEN N.V.
  • 14.8. ArcticZymes Technologies ASA
  • 14.9. Thermo Fisher Scientific, Inc.
  • 14.10. Takara Bio Inc.

15. Strategic Recommendations